Skip to content
10-Q

Quarterly Report

BIOETHICS, LTD.

0001096906-23-001540

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 1.14M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $473
Cash And Equivalents Q2 2023 · Dec 31, 2022 $295
Current Liabilities Q2 2023 · Jun 30, 2023 $730.04K
Current Liabilities Q2 2023 · Dec 31, 2022 $679.41K
Total Liabilities Q2 2023 · Jun 30, 2023 $730.04K
Total Liabilities Q2 2023 · Dec 31, 2022 $679.41K
Current Assets Q2 2023 · Jun 30, 2023 $473
Current Assets Q2 2023 · Dec 31, 2022 $295
Total Assets Q2 2023 · Jun 30, 2023 $473
Total Assets Q2 2023 · Dec 31, 2022 $295
Eps Basic Q2 2023 · Jun 30, 2023 −$0.02
Eps Basic Q2 2023 · Jun 30, 2023 −$0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.03
Eps Basic Q2 2023 · Jun 30, 2022 −$0.04
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$18.64K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$636.21K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$607.59K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$585.91K
Sga Expense Q2 2023 · Jun 30, 2022 $17.2K
Sga Expense Q2 2023 · Jun 30, 2022 $27.91K
Operating Income Q2 2023 · Jun 30, 2022 −$17.2K
Operating Income Q2 2023 · Jun 30, 2022 −$27.91K
Revenue Q2 2023 · Jun 30, 2022 $0
Revenue Q2 2023 · Jun 30, 2022 $0